Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsis

被引:43
作者
Perl, M [1 ]
Chung, CS [1 ]
Garber, M [1 ]
Huang, X [1 ]
Ayala, A [1 ]
机构
[1] Brown Univ, Sch Med, Rhode Isl Hosp, Dept Surg,Div Surg Rres, Providence, RI 02903 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2006年 / 11卷
关键词
sepsis; systemic infection; mice; human; apoptosis; immune dysfunction; organ dysfunction; review;
D O I
10.2741/1797
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sepsis is the leading cause of death in critically ill patients in the United States. It is associated with enormous expenditures within the health care system and despite substantial human, medical and fiscal resources directed at this clinical entity we have only had a modest effect on the septic patient's long- term survival. However, extensive studies over the last few decades have begun to reveal important pathophysiological processes around which a few promising therapeutic strategies with potential benefits may be derived. It is generally believed, that the body reacts to a septic challenge with an intense hyperinflammatory response, designed to eliminate the underlying pathogen. However, along with and in response to the intense pro- inflammatory reaction, mechanisms fall into place to counter regulate ( control) this initial response, typically resulting in a down regulation of the inflammatory response. This frequently results in dysfunction of various immunological conditions and may result in the inability to ward off the infection and consecutively lead to multiple organ dysfunction, multiple organ failure and death. It is the aberrant development of this anti- inflammatory/ immunosuppressive response, in which it is important to expand our understanding of pathological components to develop potential remedy. Upon this background this review aims to provide an overview on the pathophysiological mechanisms which initiate or maintain the down regulation of the immune response to a septic challenge and which might be a starting point for the development of therapeutic strategies.
引用
收藏
页码:272 / 299
页数:28
相关论文
共 319 条
[11]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[12]   NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells -: Role in phagocytic clearance [J].
Arroyo, A ;
Modriansky, M ;
Serinkan, FB ;
Bello, RI ;
Matsura, T ;
Jiang, JF ;
Tyurin, VA ;
Tyurina, YY ;
Fadeel, B ;
Kagan, VE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49965-49975
[13]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[14]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[15]  
AYALA A, 1993, ARCH SURG-CHICAGO, V128, P89
[16]  
AYALA A, 1993, IMMUNOLOGY, V79, P479
[17]   Factors responsible for peritoneal granulocyte apoptosis during sepsis [J].
Ayala, A ;
Karr, SM ;
Evans, TA ;
Chaudry, IH .
JOURNAL OF SURGICAL RESEARCH, 1997, 69 (01) :67-75
[18]  
AYALA A, 1990, IMMUNOLOGY, V70, P33
[19]   Does FAS ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis? [J].
Ayala, A ;
Xu, YX ;
Chung, CS ;
Chaudry, IH .
SHOCK, 1999, 11 (03) :211-217
[20]   Pathological aspects of apoptosis in severe sepsis and shock? [J].
Ayala, A ;
Lomas, JL ;
Grutkoski, PS ;
Chung, CS .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (01) :7-15